Press releases
* (R) = Regulatory press releases
May 9, 2023
Invitation to presentation of Cantargia’s report for the first quarter of 2023 on May 23 at 10.00 a.m. CEST
Apr 20, 2023
(R) Cantargia has submitted a phase I clinical trial application for its second project, CAN10
Apr 19, 2023
(R) Cantargia presents anti-metastatic effects of nadunolimab in cancer models at AACR 2023
Apr 4, 2023
Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023
Mar 14, 2023
